PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1803
https://www.valueinhealthjournal.com/article/S1098-3015(12)03516-4/fulltext
Title : PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03516-4&doi=10.1016/j.jval.2012.08.1803
First page : A523
Section Title : Health Services
Open access? : No
Section Order : 1295
Categories :
Tags :
Regions :
ViH Article Tags :